Ambrx Biopharma to Host Corporate Update Conference Call
11 Ottobre 2022 - 10:05PM
Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage
biopharmaceutical company using an expanded genetic code technology
platform to create Engineered Precision Biologics (EPBs), today
announced the company will host a corporate update conference call
and live webcast on October 18, 2022 at 2:00 p.m. Pacific Time /
5:00 p.m. Eastern Time, to discuss the company’s strategic review
of its development pipeline.
Individuals interested in listening to the
conference call may do so by registering via the webcast link in
the investor relations section of the company’s website at:
www.ambrx.com.
To access the call by phone, please use the
registration link on the investor relations section of the website,
and you will be provided with dial in details. To avoid delays, we
encourage participants to dial into the conference call fifteen
minutes ahead of the scheduled start time. A webcast replay will be
available in the investor relations section of the company’s
website for 90 days following the completion of the call.
About Ambrx Biopharma Inc.
(Ambrx)
Ambrx is a clinical stage biopharmaceutical
company using an expanded genetic code technology platform to
discover and develop Engineered Precision Biologics. These include
next generation antibody drug conjugates (ADCs), bispecifics,
targeted immuno-oncology therapies, novel cytokines to modulate the
immune system, and long-acting therapeutic peptides for metabolic
and cardiovascular disease. Ambrx is advancing a robust portfolio
of clinical and preclinical programs designed to optimize efficacy,
safety and ease of use, in multiple therapeutic areas, including
its lead product candidate ARX788. In addition, Ambrx has clinical
collaborations with multiple partners, for drug candidates
generated using Ambrx technology. For more information, please
visit www.ambrx.com.
Contacts
INVESTORSLaurence WattsManaging
DirectorGilmartin Group, LLC.619-916-7620ir@ambrx.com
MEDIAmedia@ambrx.com
Source: Ambrx, Inc.
Grafico Azioni Ambrx Biopharma (NYSE:AMAM)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Ambrx Biopharma (NYSE:AMAM)
Storico
Da Giu 2023 a Giu 2024